Related Experiment Video
Updated: Jun 13, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Diagnostic dilemma in a child with congenital heart disease on sildenafil
Syed Ahmed Zaki1, Deepak Dadge, Shujaath Asif
1Department of Pediatrics, Lokmanya Tilak Municipal Medical College & General Hospital, Sion, Mumbai 400 022, India.
Insights
Sildenafil treatment for infant pulmonary hypertension may cause side effects mimicking heart failure. Discontinuation of sildenafil led to dramatic improvement in a case of infant supracardiac total anomalous venous connection.
Area of Science:
- Pediatric Cardiology
- Neonatal Medicine
- Pharmacology
Background:
- Sildenafil is a common treatment for pulmonary hypertension in infants with congenital heart disease.
- Observed side effects of sildenafil can resemble congestive heart failure symptoms in children.
Purpose of the Study:
- To report a case of a two-month-old infant experiencing adverse effects attributed to sildenafil.
- To highlight potential diagnostic challenges in differentiating drug side effects from disease progression.
Main Methods:
- Case presentation of a two-month-old infant with supracardiac total anomalous venous connection and pulmonary hypertension.
- Clinical observation of symptoms including severe sweating and tachycardia following sildenafil initiation.
Main Results:
- The infant developed severe sweating and tachycardia after starting sildenafil therapy.
- These symptoms resolved dramatically upon discontinuation of sildenafil, indicating a probable drug-related adverse event.
Conclusions:
- Sildenafil therapy can present with side effects that mimic congestive heart failure in infants.
- Careful monitoring and consideration of drug-induced side effects are crucial in managing pediatric patients with pulmonary hypertension.
Abstract:
Sildenafil is used in infants and children mainly for the treatment of pulmonary hypertension associated with congenital heart disease. Some side-effects of sildenafil are similar to the symptoms and signs of congestive heart failure in children. We present a case of a two-month-old infant with supracardiac total anomalous venous connection and pulmonary hypertension, who presented with severe sweating and tachycardia after institution of sildenafil therapy. He improved dramatically on discontinuation of the drug.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiac Catheterization III: Left Heart Catheterization
